Erasca

Erasca (operating at erasca.com) is a clinical-stage precision oncology company engineered for discovering, developing, and commercializing therapies for RAS- and MAPK pathway-driven cancers. Founded in 2018 by Jonathan Lim and co-founders, and headquartered in San Diego, California, Erasca singularly focuses on solving some of oncology's toughest problems. Under the hood, the company leverages its deep RAS/MAPK pathway-focused pipeline to develop novel therapies and combination regimens. This allows patients to receive innovative treatments for their cancers. Backed by $300M in funding.